Talon Resources Targets Ontario Gold Growth After AIM Move and Eagle Lake Acquisition, CEO Says. Watch here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksPz Cussons Regulatory News (PZC)

Share Price Information for Pz Cussons (PZC)

Share Price is delayed by 15 minutes
Get Live Data
101.20    -1.60 (-1.56%)
Bid:
101.40
Ask:
102.40
Spread: 1.00 (0.986%)
Market Cap: £425.40m
PZC Live PriceLast checked at - London Stock Exchange

Intraday Pz Cussons Share Chart

Half Yearly Report

26 Jan 2010 07:00

RNS Number : 1004G
PZ CUSSONS PLC
26 January 2010
Β 

ο»Ώ

26 January 2010

INTERIM ANNOUNCEMENT OF RESULTS

FOR THE HALF YEAR TO 30 NOVEMBER 2009

PZ Cussons Plc, a leading consumer products group in personal care and household products, announces its interim results for the six months ended 30 November 2009.Β 

ResultsΒ (before exceptional items1)

Half-year to 30 November 2009Β 

Half-year toΒ 30 November 2008 (restated3)

Change

RevenueΒ 

Β£369.9m

Β£367.2m

+0.7%

Operating profit

Β£44.9m

Β£39.0m

+15.1%

Profit before taxation

Β£44.7m

Β£36.9m

+21.1%

Adjusted basic earnings per share

6.74p

5.25p

+28.4%

Statutory results

Operating profit

Β£44.9m

Β£36.9m

+21.7%

Profit before taxation

Β£44.7m

Β£34.8m

+28.4%

Basic earnings per share

6.74p

4.90p

+37.6%

Interim dividend per share

1.930p

1.185p

+62.9%

NetΒ funds /Β (debt)2

Β£25.5m

(Β£40.8m)

1Β Exceptional items are detailed in note 4.

2Β NetΒ funds /Β (debt),Β above and hereafter, are defined as cash, short-term deposits, current asset investments less borrowings.

3Β Refer to note 5.

HIGHLIGHTS

Group

StrongΒ trading performanceΒ delivered 15% increase in operating profitΒ 
Operating margins improvedΒ despiteΒ revenueΒ beingΒ flatΒ afterΒ currency impact
Diverse geographical spread of operations continues to provide platform for growth through difficult economic climateΒ 
Strong cash generation during the period funding the majorΒ capital investment programmeΒ 
Healthy balance sheet withΒ a net funds position maintained at the period end
Interim dividend increasedΒ to 1.930p per share from 1.185p per shareΒ reflecting an underlying increase of 10% and a rebalancing of the interim / final payout ratio in line with normal practice

Africa

Operating profit in Africa increased despite currency impact and a short-term liquidity squeeze inΒ NigeriaΒ which affected revenue and profitability in the second quarter

Nutrition joint ventureΒ returned toΒ profitabilityΒ and new UHT factoryΒ commissioned

Β£39m investment programme in supply chain facilities inΒ NigeriaΒ on track for completion later in the calendar year

Asia

Increase in Asia operating profit following strong performance inΒ Australia,Β IndonesiaΒ and The Middle East

Europe

Significant increase in Europe operating profits driven in particular by strong performance in theΒ UKΒ andΒ Poland

UKΒ brand portfolio benefiting from continued new product development from the integrated site at Agecroft,Β Manchester

The Sanctuary deliveredΒ year on year growthΒ which continuedΒ post period end,Β with strong performance in ChristmasΒ gifts

Β 

Commenting today, Anthony Green (Chairman) said:

"The Group has delivered a strong performance in the first half despite the economic environment remaining fragile. Investment in both our brand portfolio and our supply chain facilities has enabled us to deliver continued profitable growth in the short term as well as laying the foundations for longer term growth in all three regions in which we operate.

We continue our focus on people and our talent management programme is ensuring that we have both the number and calibre of people needed to deliver our ambitious growth plans.

Importantly, our balance sheet remains strong with continued cash generation. We are in the final year of our major capital investment programme at the end of which our supply chain facilities in our key markets ofΒ UKΒ andΒ NigeriaΒ will have been upgraded to world class standards.

Overall performance since the period end has been in line with management expectations. We remain cautiously optimistic for the full year outturn and well placed to pursue further investment opportunities."

Press Enquiries

PZΒ Cussons Brandon Leigh (FinanceΒ Director)

Hogarth John Olsen, SarahΒ MacLeod

On 26 and 27 January c/o Hogarth on 020 7357 9477. Thereafter to Brandon Leigh on 0161 491 8000.

An analysts' presentation will be held on 26 January 2010 at 9.30am at the offices of Panmure Gordon, Moorgate Hall, 155 Moorgate,Β London,Β EC2M 6XB.

Overview

PZΒ CussonsΒ PlcΒ is pleased to report that profit before tax and exceptional items roseΒ 21.1% to Β£44.7Β million (30Β November 2008: Β£36.9Β million) on revenue upΒ 0.7% to Β£369.9Β million (30Β November 2008: Β£367.2Β million). After exceptional items,Β reported profit before taxΒ increasedΒ byΒ 28.4% to Β£44.7Β million (30Β November 2008: Β£34.8Β million).Β There were no exceptional items in the six month period to 30 November 2009 (30 November 2008: charge of Β£2.1 million).Β Basic earnings per share wereΒ 6.74p (30Β November 2008:Β 4.90p). Adjusted for exceptional items, basic earnings per share roseΒ 28.4% toΒ 6.74pΒ (30Β November 2008:Β 5.25p).Β 

As atΒ 30Β November 2009Β theΒ GroupΒ had netΒ fundsΒ of Β£25.5Β million (30Β November 2008: netΒ debtΒ of Β£40.8Β million).Β 

TheΒ Board is recommending a dividend increase ofΒ 62.9%Β for the period with an interim dividendΒ ofΒ 1.930pΒ per share (30Β November 2008: 1.185p) to be paid onΒ 1Β April 2010Β to shareholders on the register at the close of business on 26Β February 2010.Β This represents both an underlying increaseΒ of 10% versus the prior periodΒ and a rebalancingΒ of the interim / final payout ratioΒ in line with normal practice.

FinancialΒ performanceΒ -Β overview

The Group has delivered a strong performance in the first half despiteΒ continued global economic uncertainty. Performance in Europe andΒ AsiaΒ has been particularly strong,Β driven by consistent execution of brand strategy in market supported by a strong pipeline of brand renovation and innovation.

In Africa, a tightening of banking controls inΒ NigeriaΒ led to a temporary lack of liquidity in the market in the second quarter which affected sales, particularly of goods in the higher value electrical goods category. In addition, a weakening of theΒ Naira has resulted in an adverse currency impact. Despite this liquidity and currency impact, and with the Nutricima joint venture returning to profitability, operating profits inΒ AfricaΒ increased versus the same period last year.

Overall exchange rate impact for the Group in the period resulted in a reduction in revenue and profitability of circaΒ Β£12m and Β£1.1mΒ respectively. Revenue, period on period, was flat, due to both the adverse currency impact and the impact inΒ NigeriaΒ of the liquidity squeeze.Β 

During the period, in addition to delivery of operating profits in absolute terms, internal focus has also been put on improving percentage margins.

Financial PositionΒ -Β overview

The Group's balance sheet remains healthyΒ and, following a return to a net funds position of Β£23.2m at the end of the last financial year, a net funds position has been maintained at this period end of Β£25.5m. Cash generated from operations was strong in the period at Β£51.5m (2008: Β£37.3m) with a continued focus on minimising working capital levels. Cash generation continues to fund the capital investment programme which has entered the last year of major organic spend with the majority of final outlay on the main Nigeria project to be paid this financial year.

Major projects

InΒ Nigeria, Project Unity, which is the Β£39 million investment in the manufacturing and broader supply chain facilities,Β is on track for completion later in the calendar year. So far the following stages of the project have been completed:Β relocation and upgrade of personal care manufacturing operations from the Ilupeju site to the Ikorodu site, installation of new soap finishing and packing equipment at the factory inΒ AbaΒ and, during the period, the commissioning of the new national distribution centre at Ikorodu. The final part of the investment is the major upgrade of the detergent production equipment also at the Ikorodu site.

Regional reviews

Performance by region

Revenue (Β£m)

Operating profit before exceptional items (Β£m)

2009

2008

2009

2008

Africa

141.2

158.3

13.8

13.3

Asia

80.0

63.1

6.1

4.9

Europe

148.7

145.8

25.0

20.8

Total

369.9

367.2

44.9

39.0

Africa

InΒ Nigeria, the political environment remains stable albeit fragile following the recent long absence of the President who has been undergoing medical treatment overseas.Β The elections inΒ NigeriaΒ are currently scheduled for spring 2011 and theΒ GroupΒ currently expectsΒ business growthΒ toΒ continue relatively unaffectedΒ throughout the processΒ as it has done through previous periods of political uncertainty. Economically,Β the NigerianΒ economy experienced a liquidity squeeze in the second quarter following a strengthening of controls in the banking sector. These reforms are viewed as positive for the long term economic health of the financial system and liquidity is now beginning to return to the market post period end. The weakening of theΒ Naira versus the US dollar has stabilised with oil prices having risen again, and positive GDP growth has continued.

Performance inΒ NigeriaΒ was strong in the first quarter followed by a weaker second quarter. Overall, and with the Nutrition joint venture returning to profitability, this has resulted in operating profits inΒ NigeriaΒ being higher than the comparative period despite the negative currency impact as a result of a 16% weakening of the Naira.Β The Group's holding in its listed Nigerian subsidiary has been increased further from 64% to 65.3%Β during the period at a cost of Β£3.4m.Β 

In Personal Care and Home Care, growth continues to be driven byΒ renovation of the core brands in haircare, skincare, babycare, medicaments and fabric care.Β In Personal Care, brands performing particularly well are Premier and Joy soaps with sales significantly ahead of the prior period, and in Home Care,Β Zip white detergent powder and Rex bulk detergent have performed well.

In Electricals,Β the HPZ joint venture with Haier experienced growth in the first quarter but slowed in the second quarter as a result of the liquidity squeeze. Harefield, the subsidiary incorporated last year to sell products in adjacent categories, has seen continued growth throughout both quarters with sales of fuel powered generators performing particularly well. Overall growth in Harefield has therefore helped to offset lower sales in HPZ.Β 

The Nutrition joint venture returned to profitability in the period following the losses incurred last year as a result of high milk prices. The business has continued to gain momentum with the Nunu brand performing particularly well. The new UHT factory was commissioned at the beginning of the period and initial sales of these products are encouraging.

GhanaΒ andΒ KenyaΒ have continued to perform wellΒ with profitability ahead of the same period last year.

Asia

InΒ Australia,Β revenue and profitability were ahead of the same period last year as a result of good execution of brand strategy in market. In laundry detergents, the Radiant and Duo brands are performing particularly well, and Morning Fresh has further extended its number one position in the dishwashing category.

RevenueΒ and profitabilityΒ inΒ IndonesiaΒ isΒ also ahead of the same period last year due to growth of both the core Cussons Baby range and also the premium Cussons First Years range which was launched last year. As a result,Β the number one position of the Cussons Baby brand has been extended further. During the period, Carex was launched into the Indonesian market to capitalise on the current heightened awareness of hand hygiene.

Growth in the region was also contributed by theΒ Middle EastΒ with revenue and profitability ahead of the prior period.

Europe

In theΒ UK, performance has been strongΒ despite a challenging trade environment with high levels of competitive promotional activity. The integrated site at Agecroft is ensuring continued speed to market of a high number of new products with our market share of the washing and bathing category increasing further. Imperial Leather continues to be the largest brand in theΒ UKΒ portfolio with emphasis in the period on ensuring delivery of great products at the right price in store. Carex sales are significantly ahead of the prior period with consumer awareness of hand hygiene remaining high following the swine flu outbreak. Carex support activity has included nationwide poster campaigns as well as a 'Hands Up For Hygiene' campaign run in schools and online. The Charles Worthington haircare brand has maintained its number two position in the competitive professional haircare category and has launched in the period an innovative new range of high performance styling products called 'Front Row'.Β The Original Source brand has experienced strong growth in the period with a growing loyal consumer base supported in particular by association with high performance sports events. Production of Original Source is currently being brought in-house at Agecroft with the addition of a new fifth line dedicated to produce this specialised range.Β 

The Sanctuary, purchased in January 2008, has continued to perform well,Β withΒ sales of gifts in the important Christmas trading period post period end ahead of last year. The brand range was extended in the period with new body care, skincare and home productsΒ includingΒ aΒ number ofΒ moreΒ premium products. The spa atΒ Covent GardenΒ has also performed well with visitor numbers close to the capacity of 64,000 per year. TwoΒ smaller high streetΒ spas,Β inΒ RichmondΒ andΒ Cambridge, are being developedΒ as part of a 'City Spa' concept to extend the reach of the spa and the brand to consumers.Β 

Revenue and profitability inΒ PolandΒ are ahead of the same period last year with good growth of 'E' laundry powder and fabric conditioner and 'Luksja' bar soap, liquid soap and shower gels.Β UKΒ innovation on personal wash hasΒ successfullyΒ been transferred to a number of the Polish products. Export sales in particular have been ahead of the prior period due to favourable exchange rates. Towards the end of the period Carex has also been launched into the Polish market in both handwash and hand gel formats.

InΒ Greece,Β whilst the olive oil market has been competitive in the first half, excellent progress has been made in growing the cheese and butter businesses acquired last year in order to expand the Minerva brand into higher margin categories.

Taxation

The effective tax rate before exceptional itemsΒ wasΒ 29.3%Β (30 November 2008: 29.0%).

Group

Richard Harvey joined the board on 1 January 2010 as Non Executive Director and Chairman elect. Richard will takeΒ over asΒ Non ExecutiveΒ Chairman on 1 July 2010 when Anthony Green, Executive Chairman, retires from the board. Graham Calder, Deputy Chairman, will retire from the board on 31 March 2010.

The Group's new Head Office atΒ ManchesterΒ BusinessΒ ParkΒ byΒ ManchesterΒ AirportΒ will open in April and will provide an innovative setting for the future.

PrincipalΒ risks and uncertainties facing theΒ Group

Our principal risks and uncertainties for the remaining six months of the financial yearΒ are explained in more detail in note 17 andΒ remain as stated on pagesΒ 24 and 25Β of our 2009Β Annual Report which is available on our website atΒ www.pzcussons.com.

OutlookΒ 

The outlook for the full year remains positive with strong performance in Europe and Asia expected to offset any continued impact inΒ NigeriaΒ of adverse exchange rates and the tightening of liquidity in the market.

The completion of the Group's major capital investment programme will lay the foundations for further profitable growth in all our regions.

The balance sheet remains strong with a net funds position and a continued focus on minimising working capital levels.

Overall performance since the period end has been in line with expectationsΒ and we remain cautiously optimistic for the full year outturn.

Β Β CONSOLIDATED BALANCE SHEET

Unaudited

UnauditedΒ (restated)Β 

AuditedΒ (restated)

30 November 2009

30 November 2008

31 May

Β 2009

Note

Β£m

Β£m

Β£m

Assets

Non-current assets

Goodwill and other intangible assets

7

160.4

151.4

157.6

Property, plant and equipment

7

211.8

215.2

200.8

Other investments

0.6

0.8

0.6

Net investment in joint venture

19.2

28.0

19.0

Receivables

1.9

0.8

1.6

Retirement benefit surplus

13

27.2

15.8

20.6

Β 

421.1

412.0

400.2

Current assets

Inventories

171.9

219.8

154.6

Trade and other receivables

129.5

141.0

113.7

Other investments

0.3

0.3

0.3

Cash and short-term deposits

83.8

41.4

84.2

Current taxation receivable

1.4

3.0

0.8

Β 

386.9

405.5

353.6

Total assets

808.0

817.5

753.8

EquityΒ 

Ordinary share capital

4.3

4.3

4.3

Capital redemption reserve

0.7

0.7

0.7

Currency translation reserve

28.9

45.6

20.4

Hedging reserve

(0.2)

(1.1)

0.3

Retained earnings

360.3

335.1

364.2

Equity attributable to equity holders of theΒ company

394.0

384.6

389.9

Equity minority interest

55.8

73.8

59.9

Total equity

449.8

458.4

449.8

Liabilities

Non-current liabilities

Borrowings

37.4

52.4

44.9

Other liabilities

1.1

2.1

1.0

Deferred tax liabilities

41.5

42.6

47.2

Retirement benefit obligations

13

55.2

42.0

29.6

Β 

135.2

139.1

122.7

Current liabilities

Borrowings

21.2

30.1

16.4

Trade and other payables

171.0

173.2

140.8

CurrentΒ income tax liabilities

27.2

15.5

20.3

ProvisionsΒ for other liabilities and charges

3.6

1.2

3.8

Β 

223.0

220.0

181.3

Total liabilities

358.2

359.1

304.0

Total equity and liabilities

808.0

817.5

753.8

Β Β CONSOLIDATED INCOME STATEMENT

Β 
Unaudited
Unaudited (restated)
Audited (restated)
Β 
Β 
Half-year to 30 November 2009
Half-year to 30 November 2008
Year to 31 May 2009
Β 
Β 
Β 
Β 
Β 
Β 
Total
Β 
Before exceptional items
Β 
Exceptional items
(note 4)
Β 
Total
Β 
Before
exceptional items
Β 
Β 
Exceptional
items
(note 4)
Β 
Β 
Total
Β 
Note
Β£m
Β£m
Β£m
Β£m
Β£m
Β£m
Β£m
Continuing operations
Β 
Β 
Β 
Β 
Β 
Β 
Β 
Β 
Revenue
3
369.9
367.2
-
367.2
781.8
-
781.8
Cost of sales
Β 
(216.8)
(227.9)
-
(227.9)
(486.7)
(3.3)
(490.0)
Β 
Β 
Β 
Β 
Β 
Β 
Β 
Β 
Β 
Gross profit
Β 
153.1
139.3
-
139.3
295.1
(3.3)
291.8
Selling and distribution costs
Β 
(64.5)
(62.8)
-
(62.8)
(123.3)
-
(123.3)
Administrative expenses
Β 
(44.5)
(36.2)
(2.1)
(38.3)
(77.1)
(1.1)
(78.2)
Share of results of joint venture
Β 
0.8
(1.3)
-
(1.3)
(4.1)
-
(4.1)
Operating profit
3
44.9
39.0
(2.1)
36.9
90.6
(4.4)
86.2
Β 
Β 
Β 
Β 
Β 
Β 
Β 
Β 
Β 
Finance income
Β 
0.9
1.3
-
1.3
3.7
-
3.7
Finance costs
Β 
(1.1)
(3.4)
-
(3.4)
(5.5)
-
(5.5)
Net finance costs
6
(0.2)
(2.1)
-
(2.1)
(1.8)
-
(1.8)
Β 
Β 
Β 
Β 
Β 
Β 
Β 
Β 
Β 
Profit before taxation
Β 
44.7
36.9
(2.1)
34.8
88.8
(4.4)
84.4
Taxation
8
(13.1)
(10.7)
0.6
(10.1)
(25.2)
Β 1.2
(24.0)
Β 
Β 
Β 
Β 
Β 
Β 
Β 
Β 
Β 
Profit for the period
Β 
31.6
26.2
(1.5)
24.7
63.6
Β (3.2)
60.4
Β 
Β 
Β 
Β 
Β 
Β 
Β 
Β 
Β 
Attributable to:
Β 
Β 
Β 
Β 
Β 
Β 
Β 
Β 
Equity holders of the company
Β 
28.8
22.4
(1.5)
20.9
52.8
(3.2)
49.6
Minority interests
Β 
2.8
3.8
-
3.8
10.8
-
10.8
Β 
Β 
31.6
26.2
(1.5)
24.7
63.6
Β (3.2)
60.4
Β 
Β 
Β 
Β 
Β 
Β 
Β 
Β 
Β 
Basic EPS (p)
10
6.74
Β 
Β 
4.90
Β 
Β 
11.64
Diluted EPS (p)
10
6.67
Β 
Β 
4.88
Β 
Β 
11.56
Β 
Β 
Β 
Β 
Β 
Β 
Β 
Β 
Β 
Adjusted basic EPS (p)
10
6.74
Β 
Β 
5.25
Β 
Β 
12.39
Adjusted diluted EPS (p)
10
6.67
Β 
Β 
5.23
Β 
Β 
12.31

Β 

CONSOLIDATEDΒ STATEMENT OFΒ COMPREHENSIVEΒ INCOME

Unaudited

UnauditedΒ 

Audited

Half-year toΒ 

30 November 2009

Half-year toΒ 

30 November 2008

Year to

31 May

Β 2009

Β£m

Β£m

Β£m

Profit for the period

31.6

24.7

Β 60.4

Other comprehensive income

ActuarialΒ (losses)Β /Β gains on defined benefit pension schemesΒ 

(19.1)

4.0

19.1

Exchange differences on translation of foreign operations

6.5

46.5

(3.8)

Cash flow hedgesΒ -Β fair valueΒ (loss) /Β gain inΒ period

(0.7)

(1.5)

0.6

Taxation on items taken directly to equity

5.5

(1.2)

(5.6)

Other comprehensiveΒ (expense) /Β income for the period net of tax

(7.8)

47.8

10.3

Total comprehensive income for the period

23.8

72.5

70.7

Attributable to:

Equity holders of the company

23.0

50.8

61.1

Minority interests

0.8

21.7

9.6

CONSOLIDATEDΒ STATEMENT OF CHANGES IN EQUITY

Attributable to owners of the company

Currency

Capital

ShareΒ 

translation

redemption

Retained

HedgingΒ 

MinorityΒ 

capital

reserve

reserve

earnings

reserve

interests

Total

Β£m

Β£m

Β£m

Β£m

Β£m

Β£m

Β£m

At 1 June 2008

4.3

23.0

0.7

320.7

-

57.2

405.9

Profit for the period

-

-

-

20.9

-

3.8

24.7

Actuarial gains on defined benefit pension schemes

-

-

-

4.0

-

-

4.0

Currency translation differencesΒ 

-

22.6

-

6.0

-

17.9

46.5

Cash flow hedgesΒ -Β fair value losses inΒ period

-

-

-

-

(1.5)

-

(1.5)

Taxation on items taken directly to equity

-

-

-

(1.6)

0.4

-

(1.2)

Total comprehensive income/(expense) for the period

-

22.6

-

29.3

(1.1)

21.7

72.5

Transactions with owners:

Ordinary dividends

-

-

-

(15.5)

-

-

(15.5)

Share based payments charge

-

-

-

0.6

-

-

0.6

Minority interest dividend paid

-

-

-

-

-

(5.1)

(5.1)

At 30 November 2008

4.3

45.6

0.7

335.1

(1.1)

73.8

458.4

At 1 June 2008

4.3

23.0

0.7

320.7

-

57.2

405.9

Profit for the period

-

-

-

49.6

-

10.8

60.4

Actuarial gains on defined benefit pension schemes

-

-

-

19.1

-

-

19.1

Currency translation differences

-

(2.6)

-

-

-

(1.2)

(3.8)

Cash flow hedges -Β fair value gains in year

-

-

-

-

0.6

-

0.6

Taxation on items taken directly to equity

-

-

-

(5.3)

(0.3)

-

(5.6)

Total comprehensive income/(expense) for the period

-

(2.6)

-

63.4

0.3

9.6

70.7

Transactions with owners:

Ordinary dividends

-

-

-

(20.5)

-

-

(20.5)

Acquisition of shares for ESOT

-

-

-

(0.7)

-

-

(0.7)

Share based payments charge

-

-

-

1.3

-

-

1.3

Acquisition of minority interest

-

-

-

-

-

(3.7)

(3.7)

Minority interest dividend paid

-

-

-

-

-

(3.2)

(3.2)

At 31 May 2009

4.3

20.4

0.7

364.2

0.3

59.9

449.8

At 1 June 2009

4.3

20.4

0.7

364.2

0.3

59.9

449.8

Profit for the period

-

-

-

28.8

-

2.8

31.6

Actuarial losses on defined benefit pension schemes

-

-

-

(19.1)

-

-

(19.1)

Currency translation differencesΒ 

-

8.5

-

-

-

(2.0)

6.5

Cash flow hedges -Β fair value losses inΒ period

-

-

-

-

(0.7)

-

(0.7)

Taxation on items taken directly to equity

-

-

-

5.3

0.2

-

5.5

Total comprehensive income/(expense) for the period

-

8.5

-

15.0

(0.5)

0.8

23.8

Transactions with owners:

Ordinary dividends

-

-

-

(17.5)

-

-

(17.5)

Acquisition of shares for ESOT

-

-

-

(2.5)

-

-

(2.5)

Share based payments charge

-

-

-

1.1

-

-

1.1

Acquisition of minority interest

-

-

-

-

-

(1.8)

(1.8)

Minority interest dividend paid

-

-

-

-

-

(3.1)

(3.1)

At 30 November 2009

4.3

28.9

0.7

360.3

(0.2)

55.8

449.8

Β Β 

CONSOLIDATEDΒ STATEMENT OFΒ CASH FLOWS

Unaudited

UnauditedΒ 

Audited

Half-year toΒ 

30Β November 2009

Half-year toΒ 

30Β November 2008

Year to

31Β May

Β 2009

Β£m

Β£m

Β£m

Operating activities

Cash generated from operations (note 11)

51.5

37.3

145.2

Taxation

(6.2)

(5.9)

(16.7)

Net cash flow from operating activities

45.3

31.4

128.5

Cash flows from investing activities

Investment income receivedΒ (note 6)

0.9

1.3

3.7

Purchase of property, plant and equipment

(18.1)

(22.9)

(46.0)

Proceeds on sale of property, plant and equipment

0.3

0.8

4.1

ProceedsΒ onΒ sale of intangible assets

-

4.3

4.3

Acquisition of intangible assets

-

-

(3.6)

Acquisition of minority interestΒ (note 14)

(3.4)

-

(5.2)

Loans granted to joint ventures

-

(0.5)

(0.5)

Acquisition of subsidiaryΒ (note 14)

(0.8)

-

-

Net cash flow from investing activities

(21.1)

(17.0)

(43.2)

Cash flows from financing activities

Interest paidΒ (note 6)

(1.1)

(3.4)

(5.5)

Dividends paid to minority interests

(3.0)

(2.0)

(2.3)

Purchase of shares for Employee Share Option Trust

(2.5)

-

(0.7)

Dividends paid to company shareholders (noteΒ 9)

(17.5)

(15.5)

(20.5)

Net decrease in borrowings

(7.5)

(4.6)

(10.5)

Net cash flow from financing activities

(31.6)

(25.5)

(39.5)

NetΒ (decrease) / increaseΒ in cash and cash equivalents

(7.4)

(11.1)

45.8

Cash and cash equivalents at the beginning of the period (note 12)

82.8

38.1

38.1

Effect of foreign exchange rates (note 12)

2.2

(2.0)

(1.1)

Cash and cash equivalents at the end of the period (note 12)

77.6

25.0

82.8

Β Β NOTES

1.Β Basis of preparation

TheseΒ condensedΒ interim financial statements for theΒ six monthsΒ endedΒ 30Β November 2009, whichΒ haveΒ been reviewedΒ butΒ not audited, have been preparedΒ in accordance with the Disclosure and Transparency Rules (DTR) of the Financial Services Authority andΒ in accordanceΒ with IAS 34, 'Interim financial reporting' as adopted by the European Union (EU).Β TheΒ condensed consolidatedΒ interim financial statements should be read in conjunction with the annual financial statements for the year endedΒ 31Β May 2009Β whichΒ have beenΒ prepared in accordance withΒ International Financial Reporting Standards (IFRS) as adopted for use in the EU, including International Accounting Standards (IAS) andΒ interpretations issued by the International Financial Reporting Interpretations Committee (IFRIC).Β 

The interim financial statements for the period endedΒ 30Β NovemberΒ 2009Β do not constitute statutory accounts within the meaning ofΒ sectionΒ 434Β of the Companies ActΒ 2006.

The financial information set out in this statement relating to the year endedΒ 31Β May 2009Β does not constitute statutory accounts for that period. Full audited accounts of the GroupΒ in respect of that financial periodΒ were approved by the Board ofΒ Directors on 28 July 2009 andΒ have beenΒ delivered to the Registrar of Companies.Β The report of the auditors on these accounts was unqualified,Β did not contain an emphasis of matter paragraphΒ and did not contain a statement underΒ sectionΒ 498Β of the Companies ActΒ 2006.

2. Accounting policies

The accounting policies adopted are consistent with those of the annual financial statements for the year ended 31 May 2009, as described in those annual financial statements,Β with the exception of the change in the accounting treatment for revenue arising on the sale of Nutricima Ltd joint venture products as explained in note 5.

Taxes on income in the interim periods are accrued using the tax rate that would be applicable to expected total annual earnings.

The following new standards, amendments to standards and interpretations have beenΒ adopted forΒ the financial year ending 31Β MayΒ 2010:

IFRS 8, 'Operating segments', effective for annual periods beginning on or after 1 January 2009. IFRS 8 replaces IAS 14 and aligns segment reporting with the requirements of theΒ USΒ standard SFAS 131, 'Disclosures about segments of an enterprise and related information'. The new standard requires aΒ 'management approach', under which segment information is presented on the same basis as that used for internal reporting purposes.Β The GroupΒ hasΒ assessed the requirements of IFRS 8 and concluded that no change in segment information is required.

IAS 1 (revised), 'Presentation of financial statements', effective for annual periods beginning on or after 1 January 2009. The GroupΒ hasΒ appliedΒ IAS 1 (amended) from 1 June 2009.

IFRIC 14, 'IAS 19 - The limit on a defined benefit asset, minimum funding requirements and their interaction'.Β The interpretation clarifies the limitations on recognising defined benefit pension surpluses (and the related deferred tax liabilities) in the balance sheet and may also require recognition of an additional liability for any committed future contributions.Β TheΒ GroupΒ has applied IFRIC 14Β from 1 June 2009.Β 

IAS 23 (amendment) 'Borrowing costs';Β IAS 32 (amendment) 'Financial instruments: presentation and consequential amendments to IAS 1 'Presentation of financial statements'; IFRS 2 (amendment) 'Share-based payment transactions'; and IFRIC 13, 'Customer loyalty programmes' also came into effect and were adopted by the GroupΒ for the year endingΒ 31 May 2010 but had no impact on the Group financial statements.

The following new standards, amendments to standards and interpretations have been issued, but are not effective for the financial year ending 31Β MayΒ 2010Β and have not been early adopted:

IFRS 3 (amendment), 'Business combinations' and consequential amendments to IAS 27, 'Consolidated and separate financial statements', IAS 28, 'Investments in associates' and IAS 31, 'Interests in joint ventures'Β areΒ effective prospectively to business combinations for which the acquisition date is on or after the beginning of the first annual reporting period beginning on or after 1 July 2009. This is applicable to the Group from 1 June 2010. Management is assessing the impact of the new requirements regarding acquisition accounting, consolidation and joint ventures on the Group.

IFRS 9Β 'Financial instruments: classification and measurement'Β is effective for accounting periods beginningΒ on orΒ after 1 January 2013. Management are assessing the impact of the new requirements on theΒ Group.

IAS 39 (amendments)Β 'Eligible hedged items', IFRIC 16Β 'Hedges of net investment in a foreign operation'Β and IFRIC 17Β 'Distributions of non cash assets to owner'Β are effective for annual periods beginning on or after 1 July 2009. Β These standards and interpretation changes are either not currently applicable to the Group or will have no material effect.Β 

3.Β Segmental analysis

The Group has three geographic sectors which are based on the location of customers and they comprise of Africa, Asia andΒ Europe. The Group has three main business sectors, being:Β toiletries and household products;Β food and nutrition;Β and electrical goods.

Geographic segmentsΒ (unaudited)Β 

Half-year to 30 November 2009

Africa

Β£m

Asia

Β£m

Europe

Β£m

Eliminations

Β£m

TotalΒ 

Β£m

Total gross segment revenue

141.2

95.3

228.2

(94.8)

369.9

Inter segment revenue

-

(15.3)

(79.5)

94.8

-

Revenue

141.2

80.0

148.7

-

369.9

Segmental operating profit before share of results of joint venture

13.0

6.1

25.0

-

44.1

Share of results of joint venture

0.8

-

-

-

0.8

Segmental operating profitΒ 

13.8

6.1

25.0

-

44.9

Half-year to 30 November 2008Β (restated)

Africa

Β£m

Asia

Β£m

Europe

Β£m

Eliminations

Β£m

TotalΒ 

Β£m

Total gross segment revenue

158.3

81.4

266.2

(138.7)

367.2

Inter segment revenue

-

(18.3)

(120.4)

138.7

-

Revenue

158.3

63.1

145.8

-

367.2

Segmental operating profit before exceptional items and share of results of joint venture

14.6

4.9

20.8

-

40.3

Share of results of joint venture

(1.3)

-

-

-

(1.3)

Segmental operating profit before exceptional items

13.3

4.9

20.8

-

39.0

Exceptional items (note 4)

-

-

(2.1)

-

(2.1)

Segmental operating profit

13.3

4.9

18.7

-

36.9

Total assets

Africa

Β£m

Asia

Β£m

Europe

Β£m

Tax and cash Β£m

TotalΒ 

Β£m

30 November 2009

245.7

103.1

374.0

85.2

808.0

30 November 2008

297.6

99.2

376.3

44.4

817.5

31 MayΒ 2009

217.8

74.3

376.7

85.0

753.8

Business segments

The following table provides an analysis of the Group's revenue by business segment.

Unaudited

UnauditedΒ (restated)

Half-year toΒ 

30Β November 2009

Half-year toΒ 

30Β November 2008

Β£m

Β£m

Toiletries and household

286.6

281.0

Food and nutrition

36.1

34.6

Electrical goods

45.5

49.8

Distribution fees

1.7

1.8

Revenue

369.9

367.2

4. Exceptional items

Restructuring ofΒ UKΒ operations

A significant restructuring of the UK business, associated with the relocation of manufacturing from theΒ previousΒ site, made up of redundancy and other associated restructuring costs resultedΒ in an exceptional charge of Β£2.1 millionΒ in the six months to 30 November 2008 and an exceptional charge of Β£4.4 million in the year ended 31 May 2009.

5.Β Prior year adjustment

During the six month period to 30 November 2009 the accounting treatment for the revenue arising from the sale of theΒ NutricimaΒ joint venture products through another Group subsidiary has been changed. In prior periods the sales (and corresponding cost of sales) relating to Nutricima Ltd (the operating entity within the Group's nutritional foods joint venture) products distributed through PZ Cussons Nigeria Plc (a subsidiary of the Group) have been recognised as revenue (and cost of sales) in the Group's income statement. Following a review of the distribution agreement conditions and the respective risks/rewards assumed by the two entities, PZ Cussons Nigeria Plc is deemed to beΒ acting asΒ an agent rather a principal (in accordance with IASΒ 18). Consequently the Group should only recognise the distribution fee income (received from Nutricima Ltd) and the related distribution costs in the consolidated income statement rather than the gross sales and cost of sales valuesΒ for the product being distributed. Furthermore, inventory relating to Nutricima products,Β held for sale by PZ Cussons Nigeria Plc,Β that had previously been consolidated in the Group's balance sheet is now accounted for as inventory within the joint venture. Importantly, there is no impact on the historic or future profitability or net assets of the Group.

The effect of this change in the half year to 30 November 2008 is to reduce revenueΒ and cost of salesΒ by Β£28.4Β million, increaseΒ revenue andΒ selling and distribution costs by Β£1.8 million, reduce inventories by Β£7.2 million,Β reduceΒ amounts owed toΒ joint venturesΒ by Β£4.5Β millionΒ and increase the amountΒ dueΒ fromΒ joint venturesΒ by Β£2.7 million. The effect of this change in the year to 31Β May 2009 is to reduce revenueΒ and cost of salesΒ by Β£60.1Β million, increaseΒ revenue andΒ selling and distribution costs by Β£3.8 million, reduce inventories by Β£3.7 million,Β Β reduceΒ amounts owed toΒ joint venturesΒ by Β£1.3Β millionΒ and increase the amountΒ dueΒ fromΒ joint venturesΒ by Β£2.4 million.

6.Β Net financeΒ (costs) /Β income

Unaudited

UnauditedΒ 

Audited

Half-year toΒ 

30Β November 2009

Half-year toΒ 

30Β November 2008

Year to

31Β May

Β 2009

Β£m

Β£m

Β£m

Net investment gains

0.1

-

0.4

Interest and dividends receivable

0.8

1.3

3.3

0.9

1.3

3.7

Interest payable on bank loans and overdrafts

(1.1)

(3.4)

(5.5)

(0.2)

(2.1)

(1.8)

7.Β Property, plant and equipment and intangible assets

Property, plant and equipment

Intangible assets

Β£m

Β£m

Opening net book amount as at 1 June 2008

180.0

152.2

Additions

24.1

-

Disposals

(0.5)

-

Depreciation and amortisation

(8.7)

-

Currency retranslation

20.3

(0.8)

Closing net book amount as at 30 November 2008

215.2

151.4

Opening net book amount as at 1 June 2009

200.8

157.6

Additions

18.2

-

AcquisitionsΒ (Note 14)

0.5

1.8

Disposals

(0.1)

-

Depreciation and amortisation

(9.0)

-

Currency retranslation

1.4

1.0

Closing net book amount as at 30 November 2009

211.8

160.4

At 30Β NovemberΒ 2009, the Group had entered into commitments for the acquisition of property, plant and equipment amounting to Β£17.2Β million. AtΒ 30Β NovemberΒ 2008, the Group had entered into capital commitments of Β£23.9Β million.Β 

8.Β Taxation

Unaudited

Unaudited

AuditedΒ 

Half-year toΒ 

30Β November 2009

Half-year toΒ 

30Β November 2008

Year to

31Β May

Β 2009

Β£m

Β£m

Β£m

United Kingdom

7.1

4.2

6.8

Overseas

6.0

5.9

17.2

13.1

10.1

24.0

Income tax expense is recognised based on management's best estimate of the weighted average annual income tax rate expected for the full financial year. The estimated average annual tax rateΒ to beΒ used for the yearΒ endingΒ 31Β May 2010Β isΒ 29%Β (the estimated tax rate for the half-yearΒ endingΒ 30Β November 2008Β wasΒ 29%).Β 

9.Β Dividends

An interim dividend ofΒ 1.930p per share for the half-year toΒ 30Β November 2009Β (30Β November 2008:Β 1.185p) has been declared totalling Β£8.3Β millionΒ (30Β November 2008:Β Β£5.1Β million)Β and isΒ payable onΒ 1Β AprilΒ 2010Β to ordinary shareholders on the register onΒ 26Β FebruaryΒ 2010. This interim dividend has not been recognised in this half yearly report.Β The proposed final dividendΒ for the year endedΒ 31Β May 2009Β ofΒ 4.085p per share, totalling Β£17.5Β million,Β was approved by shareholders at the annual general meeting of theΒ company and paid onΒ 7Β OctoberΒ 2009.

10.Β Earnings per share

Basic earnings per share and diluted earnings per share are calculated by dividing profit for the periodΒ by the following weighted average number of shares in issue:

Unaudited

Unaudited

AuditedΒ 

Half-year toΒ 

30Β NovemberΒ 2009

Half-year toΒ 

30Β November 2008

Year to

31Β May

Β 2009

Basic weighted average (000)

427,253

426,665

426,212

Diluted weighted average (000)

431,686

428,699

429,064

The difference between the basic and diluted weighted average number of shares represents the dilutive effect of the deferred annual share bonus scheme,Β executive share option schemes and performance share plan. The basic and diluted earnings per share for the period are as follows:

Unaudited

Unaudited

AuditedΒ 

Half-year toΒ 

30Β November 2009

Half-year toΒ 

30Β November 2008

Year to

31Β May

Β 2009

Basic earnings per share:

-Β Adjusted basic earnings per share

6.74p

5.25p

12.39p

-Β Exceptional items

-

(0.35)p

(0.75)p

-Β Basic earnings per share

6.74p

4.90p

11.64p

Diluted earnings per share:

-Β Adjusted diluted earnings per share

6.67p

5.23p

12.31p

-Β Exceptional items

-

(0.35)p

(0.75)p

-Β Diluted earnings per shareΒ 

6.67p

4.88p

11.56p

11. Reconciliation ofΒ profitΒ before taxationΒ to cash generated fromΒ operations

Unaudited

Unaudited

AuditedΒ 

Half-year toΒ 

30Β November 2009

Half-year toΒ 

30Β November 2008

Year to

31Β May

Β 2009

Β£m

Β£m

Β£m

Profit before taxation

44.7

34.8

84.4

Adjustment for finance costs

0.2

2.1

1.8

Operating profit

44.9

36.9

86.2

Depreciation

9.0

8.7

17.5

Loss/(profit)Β on sale of tangible fixed assets

(0.2)

(0.3)

1.0

Difference between pension charge and cash contributions

(1.4)

(1.3)

(2.6)

Share of result from joint ventures

(0.8)

1.3

4.1

Share based payments

1.1

0.6

1.3

Operating cash flows before movements in working capital

52.6

45.9

107.5

Movements in working capital:

Inventories

(16.5)

(29.9)

7.0

Receivables

(14.9)

(12.7)

(2.0)

Payables

29.4

33.3

30.7

Provisions

0.9

0.7

2.0

Cash generated from operations

51.5

37.3

145.2

12.Β NetΒ fundsΒ reconciliationΒ 

Group netΒ fundsΒ comprises the following:

Audited

Unaudited

Unaudited

Unaudited

UnauditedΒ 

1Β June 2009

Cash flow

Foreign Exchange

Non cash items

30Β November 2009

Β£m

Β£m

Β£m

Β£m

Β£m

Cash at bank and in hand

38.9

1.5

1.1

-

41.5

Overdrafts

(1.4)

(4.8)

-

-

(6.2)

Short term deposits

45.3

(4.1)

1.1

-

42.3

Cash and cash equivalents

82.8

(7.4)

2.2

-

77.6

Current asset investments

0.3

-

-

-

0.3

Bank loans less than 1 year

(15.0)

7.5

-

(7.5)

(15.0)

Bank loans greater than 1 year

(44.9)

-

-

7.5

(37.4)

NetΒ funds

23.2

0.1

2.2

-

25.5

13. Retirement BenefitsΒ 

The Group operates retirement benefit schemes for most of itsΒ UKΒ and overseas subsidiaries. These obligations have been measured in accordance with IAS 19 and are as follows:

Unaudited

Unaudited

AuditedΒ 

30 November 2009

30Β November 2008

31Β May

Β 2009

Β£m

Β£m

Β£m

UKΒ schemes inΒ surplus

27.2

15.8

20.6

UKΒ schemesΒ inΒ deficit

(49.1)

(36.9)

(24.9)

Overseas schemes

(6.1)

(5.1)

(4.7)

(28.0)

(26.2)

(9.0)

TheΒ Group has three mainΒ defined benefit schemesΒ which are based and administered in theΒ UKΒ and are now closedΒ toΒ future accrual.Β 

The amounts recognised in the balance sheetΒ in relation to theseΒ UKΒ schemesΒ are determined as follows:

Unaudited

Unaudited

AuditedΒ 

30Β November 2009

30Β November 2008

31Β May

Β 2009

Β£m

Β£m

Β£m

Present value of scheme liabilities

(250.8)

(210.6)

(196.1)

Fair value of scheme assets

228.9

189.5

191.8

Retirement benefit deficit

(21.9)

(21.1)

(4.3)

The key financial assumptions applied in the actuarial review of the pension schemes have been reviewed in the preparation of these interim accounts and amended where appropriate.Β The principal assumptions made were:

Unaudited

Unaudited

AuditedΒ 

Half-year toΒ 

30Β November 2009

Half-year toΒ 

30Β November 2008

Year to

31Β May

Β 2009

% per annum

% per annum

% per annum

Rate of increase in salaries

4.40

4.00

4.50

Rate of increase in retirement benefits in payment

3.40

3.00

3.50

Discount rate

5.50

6.00

7.00

Inflation assumption

3.40

3.00

3.50

The last triennial actuarial valuations of the schemes administered in theΒ UKΒ were performed by independent professional actuaries at 1 June 2006.Β 

The movement during the period is as follows:

UnauditedΒ 

Β£m

Retirement benefit deficitΒ as at 1Β JuneΒ 2009

(4.3)

Expected return on scheme assets

6.1

Interest cost

(6.8)

Employer contributions

2.1

ActuarialΒ loss

(19.0)

Retirement benefit deficitΒ as at 30 November 2009

(21.9)

Β 

The total income statement charge of Β£0.7 million has been recognised within administrative expenses.

14.Β Acquisitions

On 5 November 2009, the Group, through its subsidiary The Sanctuary at Covent GardenΒ Ltd, acquired the entire share capital of Body ExperienceΒ Ltd, aΒ company registered in theΒ UKΒ whose principal activity is the provision of spa services. The consideration was Β£0.8 million andΒ provisionalΒ goodwill arising on the acquisition was Β£0.2 million.

ThroughoutΒ the period from 1 June 2009 to 30 November 2009, the Group has acquired additional share capital ofΒ its existing subsidiaryΒ PZ Cussons Nigeria Plc, increasing the Group's stake from 64% to 65%. The consideration for these additional shares was Β£3.4 million and goodwill arising on the acquisition was Β£1.6 million.

15.Β Related party transactions

The following related party transactions were entered into by subsidiary companies during theΒ periodΒ under the terms of a joint venture agreement with Glanbia Plc.

AtΒ 30Β November 2009Β the outstanding balance receivable from Milk Ventures (UK) Ltd was Β£23.8Β million (31Β May 2009: Β£23.8Β million).Β There wereΒ no outstandingΒ balancesΒ payable to Milk VenturesΒ (UK) LtdΒ (31Β May 2009: nil).

The Group sourced and then sold fixed assets and raw materials to Nutricima Ltd to the value of Β£11.0Β million (30 NovemberΒ 2008: Β£26.9Β million). AtΒ 30Β November 2009Β the amount outstanding from Nutricima Ltd was Β£1.1Β million (31Β May 2009: Β£8.5Β million).

PZ Cussons Nigeria PlcΒ distributed goods on behalf ofΒ Nutricima LtdΒ to the value ofΒ Β£25.5Β million (30Β NovemberΒ 2008: Β£28.4Β million). The amount outstanding fromΒ Nutricima LtdΒ atΒ 30Β November 2009Β was Β£1.9Β million (31Β May 2009: Β£2.7Β million).Β All trading balances will be settled in cash.

There were no provisions for doubtful related party receivables atΒ 30Β November 2009Β (31Β May 2009: nil) and no charge to the income statement in respect of doubtful related party receivables (30Β November 2008: nil).

16.Β Seasonality

Certain individual business units have a degree of seasonality with the biggest factors being the weather and Christmas. However, no individual reporting segment is seasonal as a whole and therefore no further analysis is provided.Β 

17.Β Principal risks and uncertainties

The principal risks affecting theΒ Group and measures taken to reduce these risks are explained in detail on pages 24 and 25 of our 2009 Annual Report which is available on our website at www.pzcussons.com. The risks were categorised as market risk, financial risk and operational risk and are summarised as follows:

Market risks identified are: political and economic stability due to substantial operations in emerging markets; demand risk arising from changes in consumer preferences and the competitive environment in which the Group operates; and raw material risk relating to price and supply fluctuations in raw materials used in production.

The major financial risk identified is foreign currency and treasury risk due to the international nature of the Group.

Operational risks identified are: the ability to retain and recruit the right calibre of people at all levels; and reputational risk as a result of failure to meet safety, social, environmental and ethical standards in all operations and activities.

The Group Risk Committee is responsible for ensuring where possible actions are taken to manage and mitigate the risks identified.

STATEMENT OF DIRECTORS' RESPONSIBILITIES

TheΒ Directors' confirm that this condensed consolidated interim financial information has been prepared in accordance with IAS 34 as adopted by the European Union and that the interim management report includes a fair review of the information required by DTR 4.2.7 and DTR 4.2.8, namely:

an indication of important events that have occurred during the first six months and their impact on the condensed set of financial statements, and a description of the principal risks and uncertainties for the remaining six months of the financial year; and

material related party transactions in the first six months and any material changes in the related-party transactions described in the last annual report.

TheΒ Directors are responsible for the maintenance and integrity of theΒ Company's website. Legislation in theΒ United KingdomΒ governing the preparation and dissemination of financial statements may differ from legislation in otherΒ jurisdictions. The currentΒ Directors are listed at the end of this announcement.

By order of the Board

Brandon Leigh

Finance Director

26Β January 2010

Β Β 

INTERIM REVIEW REPORT TO PZ CUSSONS PLC

Introduction

We have been engaged by theΒ Company to review the condensed set of financial statements in the half-yearly financial report for the six months ended 30 November 2009, which comprises theΒ ConsolidatedΒ Balance Sheet,Β the Consolidated Income Statement,Β theΒ ConsolidatedΒ Statement of Comprehensive Income, theΒ ConsolidatedΒ Statement of Changes in Equity,Β theΒ ConsolidatedΒ Statement of Cash Flows,Β and related notes. We have read the other information contained in the half-yearly financial report and considered whether it contains any apparent misstatements or material inconsistencies with the information in the condensed set of financial statements.

Directors' responsibilities

The half-yearly financial report is the responsibility of, and has been approved by, theΒ Directors. TheΒ Directors are responsible for preparing the half-yearly financial report in accordance with the Disclosure and Transparency Rules of theΒ United Kingdom's Financial Services Authority.

As disclosed in note 1, the annual financial statements of theΒ Group are prepared in accordance with IFRSs as adopted by the European Union. The condensed set of financial statements included in this half-yearly financial report has been prepared in accordance with International Accounting Standard 34, "Interim Financial Reporting", as adopted by the European Union.

Our responsibility

Our responsibility is to express to theΒ Company a conclusion on the condensed set of financial statements in the half-yearly financial report based on our review. This report, including the conclusion, has been prepared for and only for the company for the purpose of the Disclosure and Transparency Rules of the Financial Services Authority and for no other purpose. We do not, in producing this report, accept or assume responsibility for any other purpose or to any other person to whom this report is shown or into whose hands it may come save where expressly agreed by our prior consent in writing.

Scope of review

We conducted our review in accordance with International Standard on Review Engagements (UKΒ andΒ Ireland) 2410, 'Review of Interim Financial Information Performed by the Independent Auditor of the Entity' issued by the Auditing Practices Board for use in theΒ United Kingdom. A review of interim financial information consists of making enquiries, primarily of persons responsible for financial and accounting matters, and applying analytical and other review procedures. A review is substantially less in scope than an audit conducted in accordance with International Standards on Auditing (UKΒ andΒ Ireland) and consequently does not enable us to obtain assurance that we would become aware of all significant matters that might be identified in an audit. Accordingly, we do not express an audit opinion.

Conclusion

Based on our review, nothing has come to our attention that causes us to believe that the condensed set of financial statements in the half-yearly financial report for the six months ended 30 November 2009 is not prepared, in all material respects, in accordance with International Accounting Standard 34 as adopted by the European Union and the Disclosure and Transparency Rules of the United Kingdom's Financial Services Authority.

PricewaterhouseCoopersΒ LLP Chartered Accountants 26 January 2010Manchester

Β 

Directors

Chairman

A J Green

Deputy Chairman

A G Calder

Chief Executive

G A KanellisΒ 

J AΒ ArnoldΒ *

C GΒ Davis

R J Harvey *Β (appointed 1Β January 2010)

S JΒ N HealeΒ *

B H Leigh

D W Lewis *

J PantelireisΒ 

J T J Steel *Β 

* Non-executive

Secretary

S P Plant

Registered Office

PZ Cussons House

Bird Hall Lane

StockportΒ SK3 0XN

Registered number

Company registered number 19457

Registrars

Computershare Investor Services PLC

PO BoxΒ 82

The Pavilions

Bridgwater Road

BristolΒ BS99 7NH

Website

www.pzcussons.com

This information is provided by RNS
The company news service from the London Stock Exchange
Β 
END
Β 
Β 
IR KKPDNFBKDKDB
Date   Source Headline
1st Aug 20147:00 amRNSAcquisition of Australian food brand five:am
29th Jul 20147:00 amRNSFinal Results
1st Jul 20145:30 pmRNSDirector/PDMR Shareholding
12th Jun 20147:00 amRNSTrading Update
10th Apr 20147:00 amRNSInterim Management Statement
31st Mar 201412:08 pmRNSDirector/PDMR Shareholding
14th Feb 20149:32 amRNSSale of Polish Home Care brands
12th Feb 20147:00 amRNSAppointment of a new Non-executive Director
6th Feb 20141:00 pmRNSSale of Polish Home Care brands
3rd Feb 20145:30 pmRNSDirector/PDMR Shareholding
23rd Jan 20145:30 pmRNSDirector/PDMR Shareholding
21st Jan 20147:00 amRNSHalf Yearly Report
31st Dec 201312:30 pmRNSDirector/PDMR Shareholding
11th Dec 20137:00 amRNSTrading Update
19th Nov 20135:30 pmRNSHolding(s) in Company
1st Nov 20135:30 pmRNSHolding(s) in Company
29th Oct 20136:06 pmRNSHolding(s) in Company
30th Sep 20132:09 pmRNSDirector/PDMR Shareholding
25th Sep 20135:30 pmRNSResult of AGM
25th Sep 20137:00 amRNSInterim Management Statement
15th Aug 20135:30 pmRNSDirector/PDMR Shareholding
5th Aug 20135:30 pmRNSDirector/PDMR Shareholding
25th Jul 20135:30 pmRNSDirector/PDMR Shareholding
23rd Jul 20137:00 amRNSFinal Results
2nd Jul 20137:00 amRNSAcquisition of Rafferty's Garden
1st Jul 20132:30 pmRNSDirector/PDMR Shareholding
13th Jun 20137:00 amRNSTrading Update
21st May 20137:00 amRNSPresentations to investors
26th Apr 20132:08 pmRNSHolding(s) in Company
11th Apr 20137:00 amRNSInterim Management Statement
2nd Apr 20139:53 amRNSDirector/PDMR Shareholding
28th Mar 20136:00 pmRNSDirector/PDMR Shareholding
22nd Feb 20135:30 pmRNSDirector/PDMR Shareholding
20th Feb 20137:00 amRNSSALE OF POLISH HOME CARE BRANDS
29th Jan 20137:00 amRNSHalf Yearly Report
31st Dec 201211:13 amRNSDirector/PDMR Shareholding
6th Dec 20127:00 amRNSTrading Statement
30th Nov 20126:16 pmRNSAnnual Information Update
23rd Nov 20128:27 amRNSHolding(s) in Company
1st Oct 20122:53 pmRNSDirector/PDMR Shareholding
19th Sep 20125:30 pmRNSResult of AGM
19th Sep 20127:00 amRNSInterim Management Statement
28th Aug 20128:54 amRNSDirector/PDMR Shareholding
15th Aug 20125:00 pmRNSDirector/PDMR Shareholding
26th Jul 20121:25 pmRNSDirector/PDMR Shareholding
24th Jul 20127:00 amRNSFinal Results
2nd Jul 20127:00 amRNSPresentations to investors
29th Jun 201210:23 amRNSDirector/PDMR Shareholding
14th Jun 20127:00 amRNSTrading Update
16th May 20126:30 pmRNSHolding(s) in Company

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.